Danny Chichester

Thallion Pharmaceuticals, Inc. is a biotechnology company focused on developing new pharmaceutical products in the areas of infectious disease and oncology. Its products are Shigamabs, a dual antibody product for the treatment of Shigatoxin-producing E. coli bacterial infections and TLN-4601, a proprietary first in class small molecule with potential efficacy in multiple oncology indications. The company was founded in January 1998 and is headquartered in Dorval, Canada.

Kompas Medical Services, Inc. provides pharmaceutical development services. It offers pre clinical, clinical development, development of medical strategy, evaluation, scientific and medical strategy, optimization of research organization services. It serves to the biotech companies, venture capital firms and other institution in health sciences. The company was founded by Danny L. Chichester in 2007 and is headquartered in Montréal, Canada.

Neomed Institute operated as a non-profit organization for pharmaceutical companies. It offered analytical services, drug development, licensing, and drug discovery. The company was founded in 2012 and was headquartered in Montreal, Canada.